Matinas BioPharma Appoints Cochleate Technology Pioneer Raphael J. Mannino, Ph.D., as Senior Vice President and Chief Technology Officer

Co-Inventor of the Company's Proprietary Lipid-Crystal Nano-Particle Cochleate Technology Joins Management Sept. 1 BEDMINSTER, N.J., Sept. 1, 2015 -- (Healthcare Sales & Marketing Network) -- Matinas BioPharma Holdings, Inc. (MTNB), a clinical-stage bio... Biopharmaceuticals, Drug Delivery, PersonnelMatinas BioPharma, nano-particle, amphotericin B
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news